Earnings

Despite reporting progress in its pivotal Phase 3 trial for a hepatitis C combination therapy, Atea Pharmaceuticals Inc. witnessed its...

Autolus Therapeutics presents investors with a compelling puzzle. The clinical-stage biopharmaceutical company boasts a recently approved cancer therapy and impressive...

The semiconductor sector's spotlight turns to Broadcom this week as the chip manufacturer prepares to report quarterly earnings. Having emerged...

While broader real estate markets face significant pressure, one specialized manufacturer of budget-friendly factory-built homes continues to deliver exceptional performance....

Furniture manufacturer MillerKnoll delivered a complex financial performance in its latest quarterly report, presenting investors with both encouraging results and...

While much of the technology sector faces headwinds, Blackbaud has demonstrated remarkable operational resilience. The provider of software solutions for...

Healthcare services provider Mednax has captured market attention with a robust quarterly performance and a significant new capital return initiative....

While technology stocks dominate headlines, a specialized environmental services company is demonstrating remarkable operational and financial improvement. Montrose Environmental Group...

The age of boundless AI euphoria appears to be ending, at least for one specialist player. As the broad speculative...

Radiation therapy specialist Accuray Incorporated has reported a mixed financial performance for its most recent fiscal year. The company's service...